The Brazilian INPI's 2025 report reveals the leading IP applicants in the country. Key findings show the US and China dominating foreign patent filings, with Huawei surpassing Qualcomm for the top spot while public universities drive local R&D. In trademarks, the service and retail sectors lead the domestic market, accompanied by a rising trend of digital influencers and public figures actively securing their brand rights.

Three Resolutions from the Board of Directors were presented to address issues of access to products and scientific research initiatives which, according to the President of Anvisa (Brazilian Health Regulatory Agency), fulfill the role of the Health Surveillance Agency in "providing responsible, evidence-based regulatory responses so that the patient is at the center of decisions.". The regulation is exclusively for medicinal purposes and considers all established sanitary rules. The President of Anvisa states that this is a step that brings concrete hope to thousands of Brazilian families.

On December 2, 2025, the Brazilian IP Office (INPI) held the first meeting for dialogue between the parties to present proposals for the Regulation of Alternative Set of Claims in patent applications. The conceptual premises guiding the proposed regulation were presented, addressing points such as the potential advantages of regulation for users, including greater flexibility, a reduction in examination process steps, and greater alignment with international practices. The expected impact on INPI was also discussed, which anticipates a possible increase in workload during the Alternative Claims presentation stage, but with a potential reduction in the time required for patent granting.